Somatic Evolution in Non-neoplastic IBD-Affected Colon.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
06 08 2020
Historique:
received: 08 03 2020
revised: 01 05 2020
accepted: 24 06 2020
pubmed: 23 7 2020
medline: 30 3 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Inflammatory bowel disease (IBD) is a chronic inflammatory disease associated with increased risk of gastrointestinal cancers. We whole-genome sequenced 446 colonic crypts from 46 IBD patients and compared these to 412 crypts from 41 non-IBD controls from our previous publication on the mutation landscape of the normal colon. The average mutation rate of affected colonic epithelial cells is 2.4-fold that of healthy colon, and this increase is mostly driven by acceleration of mutational processes ubiquitously observed in normal colon. In contrast to the normal colon, where clonal expansions outside the confines of the crypt are rare, we observed widespread millimeter-scale clonal expansions. We discovered non-synonymous mutations in ARID1A, FBXW7, PIGR, ZC3H12A, and genes in the interleukin 17 and Toll-like receptor pathways, under positive selection in IBD. These results suggest distinct selection mechanisms in the colitis-affected colon and that somatic mutations potentially play a causal role in IBD pathogenesis.

Identifiants

pubmed: 32697969
pii: S0092-8674(20)30813-8
doi: 10.1016/j.cell.2020.06.036
pmc: PMC7427325
pii:
doi:

Substances chimiques

ARID1A protein, human 0
DNA-Binding Proteins 0
F-Box-WD Repeat-Containing Protein 7 0
FBXW7 protein, human 0
Interleukin-17 0
OSCAR protein, human 0
Receptors, Cell Surface 0
Toll-Like Receptors 0
Transcription Factors 0
Ribonucleases EC 3.1.-
ZC3H12A protein, human EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

672-684.e11

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests C.A.A. is a paid consultant for Genomics plc and Bristol-Myers Squibb. All other authors declare no competing interests.

Références

Nature. 2020 Feb;578(7793):122-128
pubmed: 32025013
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):789-99
pubmed: 23448792
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16910-5
pubmed: 20837533
Immunity. 2016 Mar 15;44(3):659-671
pubmed: 26982366
Am J Gastroenterol. 2016 Nov;111(11):1599-1607
pubmed: 27481309
Nat Immunol. 2011 Oct 30;12(12):1167-75
pubmed: 22037600
J Gastroenterol. 2019 Jul;54(7):628-640
pubmed: 30756187
Gut. 2012 Dec;61(12):1693-700
pubmed: 22595313
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Mucosal Immunol. 2018 Jul;11(4):1203-1218
pubmed: 29695841
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.10.1-15.10.18
pubmed: 27930805
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Mayo Clin Proc. 2006 Nov;81(11):1462-71
pubmed: 17120402
Nature. 2016 Oct 13;538(7624):260-264
pubmed: 27698416
Science. 2018 Nov 23;362(6417):911-917
pubmed: 30337457
Gut. 2016 Jun;65(6):889-93
pubmed: 27008845
Nature. 2020 Jan;577(7789):254-259
pubmed: 31853059
Nat Rev Gastroenterol Hepatol. 2017 Apr;14(4):218-229
pubmed: 28174420
Cell. 2010 Oct 1;143(1):134-44
pubmed: 20887898
BMC Evol Biol. 2018 Feb 2;18(1):11
pubmed: 29390973
Curr Protoc Bioinformatics. 2016 Dec 8;56:15.9.1-15.9.17
pubmed: 27930809
Science. 2015 May 22;348(6237):880-6
pubmed: 25999502
Nature. 2009 Apr 30;458(7242):1185-90
pubmed: 19322177
Nature. 2020 Apr;580(7802):269-273
pubmed: 32106218
J Am Acad Dermatol. 2017 Mar;76(3):441-448.e2
pubmed: 28027825
Immunity. 2015 Sep 15;43(3):475-87
pubmed: 26320658
Nature. 2019 Oct;574(7779):538-542
pubmed: 31645727
Clin Cancer Res. 2018 Oct 15;24(20):5133-5142
pubmed: 29950348
BMC Gastroenterol. 2019 Sep 5;19(1):162
pubmed: 31488067
Nature. 2020 Jan;577(7789):260-265
pubmed: 31853061
N Engl J Med. 2015 Apr 9;372(15):1441-52
pubmed: 25853748
Gastroenterology. 2014 Nov;147(5):990-1007.e3
pubmed: 25058236
Nature. 2004 Jul 8;430(6996):218-22
pubmed: 15241416
Gut. 2013 Dec;62(12):1795-805
pubmed: 24203055
Nat Genet. 2020 Mar;52(3):306-319
pubmed: 32024998
Bioinformatics. 2014 May 1;30(9):1198-204
pubmed: 24443148
J Exp Med. 1999 Oct 4;190(7):915-22
pubmed: 10510081
Nature. 2020 Feb;578(7793):94-101
pubmed: 32025018
Cell. 2019 Apr 18;177(3):608-621.e12
pubmed: 30955891
Cell Stem Cell. 2018 Jun 01;22(6):909-918.e8
pubmed: 29779891
Mucosal Immunol. 2011 Nov;4(6):598-602
pubmed: 21956244
Nature. 2019 Nov;575(7781):210-216
pubmed: 31645765
Int J Cancer. 1998 Mar 30;76(1):1-6
pubmed: 9533753
Gastroenterology. 2012 Apr;142(4):855-864.e8
pubmed: 22178590
Nature. 2020 Feb;578(7794):266-272
pubmed: 31996850
Science. 2010 Nov 5;330(6005):822-5
pubmed: 20929733
Gut. 1992 Jan;33(1):71-8
pubmed: 1740282
Bioinformatics. 2009 Nov 1;25(21):2865-71
pubmed: 19561018
Nature. 2019 Jan;565(7739):312-317
pubmed: 30602793
Nature. 2013 Aug 22;500(7463):415-21
pubmed: 23945592
Gastroenterology. 2009 Feb;136(2):542-50.e6
pubmed: 19103203
Gut. 2019 Jun;68(6):985-995
pubmed: 29991641
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
World J Gastroenterol. 2014 Jun 14;20(22):6815-20
pubmed: 24944471
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Am J Epidemiol. 2013 Jun 1;177(11):1296-305
pubmed: 23514635
Cell. 2015 May 21;161(5):1058-1073
pubmed: 26000482
Gastroenterology. 2016 Apr;150(4):931-43
pubmed: 26764183
Cell Rep. 2018 Aug 14;24(7):1777-1789
pubmed: 30110635
Nature. 2020 Apr;580(7805):640-646
pubmed: 32350471
Case Rep Gastroenterol. 2018 Oct 17;12(3):617-621
pubmed: 30483039
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Am J Gastroenterol. 2015 Jul;110(7):1022-34
pubmed: 25823771

Auteurs

Sigurgeir Olafsson (S)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Rebecca E McIntyre (RE)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Tim Coorens (T)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Timothy Butler (T)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Hyunchul Jung (H)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Philip S Robinson (PS)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; University of Cambridge, Department of Paediatrics, Cambridge CB2 0QQ, UK.

Henry Lee-Six (H)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Mathijs A Sanders (MA)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK; Department of Hematology, Erasmus University Medical Center, Postbus 2040, 3000 CA Rotterdam, the Netherlands.

Kenneth Arestang (K)

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Claire Dawson (C)

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Monika Tripathi (M)

Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Konstantina Strongili (K)

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Yvette Hooks (Y)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Michael R Stratton (MR)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Miles Parkes (M)

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Inigo Martincorena (I)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Tim Raine (T)

Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridgeshire CB2 0QQ, UK.

Peter J Campbell (PJ)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.

Carl A Anderson (CA)

Wellcome Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: carl.anderson@sanger.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH